Avian influenza: Update

Medical Principles and Practice

Volumn 19, Issue 6, 2010, Pages 421-432

  Adams, Sean ^a   Sandrock, Christian ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Avian influenza virus; Clades; Clinical signs; Epidemiology; H5N1; Vaccine

Indexed keywords

AMANTADINE; AMINOTRANSFERASE; AVIAN INFLUENZA VACCINE; CELL SURFACE PROTEIN; COMPLEMENTARY RNA; CORTICOSTEROID; CREATINE KINASE; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; NONSTRUCTURAL PROTEIN 1; OSELTAMIVIR; RIBAVIRIN; RIBONUCLEOPROTEIN; RIMANTADINE; SIALIC ACID; SIALIDASE; ZANAMIVIR;

ACUTE KIDNEY TUBULE NECROSIS; ACUTE RESPIRATORY TRACT DISEASE; AMINOTRANSFERASE BLOOD LEVEL; ARTIFICIAL VENTILATION; ATROPHY; AVIAN INFLUENZA; BIRD; BRONCHOSCOPY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; CREATINE KINASE BLOOD LEVEL; CYTOKINE STORM; DRUG RESISTANCE; DYSPNEA; FEVER; GENETIC DRIFT; HOST RANGE; HUMAN; HYPOALBUMINEMIA; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N7; LACTATE DEHYDROGENASE BLOOD LEVEL; LIPID BILAYER; LIVER NECROSIS; LUNG HEMORRHAGE; LYMPHOCYTOPENIA; MAMMAL; MULTIPLE ORGAN FAILURE; NAUSEA; NEBULIZER; NUCLEOTIDE SEQUENCE; PNEUMONIA; PNEUMOTHORAX; RESPIRATORY TRACT INTUBATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; REYE SYNDROME; THROMBOCYTOPENIA; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA; VIRUS MORPHOLOGY; VOMITING;

ANTIVIRAL AGENTS; COMMUNICABLE DISEASE CONTROL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; WORLD HEALTH;

EID: 77957659909     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320299     Document Type: Review

References (104)

1. Influenza (seasonal) fact sheet. Geneva World Health Organization 2009. http://www.who.int/mediacentre/factsheets/fs211/ en/ (accessed February 11 2010).
2. Highly pathogenic avian influenza: manual of diagnostic tests and vaccines for terrestrial animals. Paris, Office International des Epizooties 2000. http://www.oie.int/eng/ normes/mmanual/A-00037.htm (accessed February 11 2010).
3. Kido H, Okumura Y, Takahashi E, Pan HY, Wang S, Chida J, Le TQ, Yano M: Host envelope glycoprotein-processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses. J Mol Genet Med 2008; 3: 167-175.
4. Murti KG, Webster RG, Jones IM: Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology 1988; 164:562-566.
5. Palese P, Shaw M: Orthomyxoviridae: the viruses and their replication; in Knipe D, Howley P (eds): Fields Virology, ed 5. Philadelphia, Lippincott Williams and Wilkins, 2006, pp 1647-1689.
6. Gocnikova H, Russ G: Influenza A virus PB1-F2 protein. Acta Virol 2007; 51: 101-108.
7. Hale BG, Randall RE, Ortín J, Jackson D: The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008; 89: 2359-2376.
8. Kawaoka Y, Webster RG: Molecular mechanism of acquisition of virulence in influenza virus in nature. Microb Pathog 1988; 5:311-318.
9. Kendal AP: Epidemiologic implications of changes in the influenza virus genome. Am J Med 1987; 82: 4-14.
10. Bouvier NM, Palese P: The biology of influenza viruses. Vaccine 2008; 26(suppl 4):D49-D53.
11. Suarez DL, Senne DA, Banks J, Brown IH, Essen SC, Lee CW, Manvell RJ, Mathieu-Benson C, Moreno V, Pedersen JC, Panigrahy B, Rojas H, Spackman E, Alexander DJ: Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis 2004; 10: 693-699.
12. Cardona CJ, Xing Z, Sandrock CE, Davis CE: Avian influenza in birds and mammals. Comp Immunol Microbiol Infect Dis 2009; 32:255-273.
13. Ellis TM, Bousfield RB, Bissett LA, Dyrting KC, Luk GS, Tsim ST, Sturm-Ramirez K, Webster RG, Guan Y, Malik Peiris JS: Investigation of outbreaks of highly pathogenic H5N1 avian influenza in waterfowl and wild birds in Hong Kong in late 2002. Avian Pathol 2004; 33:492-505.
14. Kelly TR, Hawkins MG, Sandrock CE, Boyce WM: A review of highly pathogenic avian influenza in birds, with an emphasis on Asian H5N1 and recommendations for prevention and control. J Avian Med Surg 2008; 22:1-16.
15. Kou Z, Lei FM, Yu J, Fan ZJ, Yin ZH, Jia CX, Xiong KJ, Sun YH, Zhang XW, Wu XM, Gao XB, Li TX: New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. J Virol 2005; 79: 15460-15466.
16. Liu J, Xiao H, Lei F, Zhu Q, Qin K, Zhang XW, Zhang XL, Zhao D, Wang G, Feng Y, Ma J, Liu W, Wang J, Gao GF: Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 2005; 309:1206.
17. Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, Seiler P, Govorkova EA, Krauss S, Scholtissek C, Puthavathana P, Buranathai C, Nguyen TD, Long HT, Naipospos TS, Chen H, Ellis TM, Guan Y, Peiris JS, Webster RG: Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci USA 2005; 102:10682-10687.
18. Kawaoka Y, Yamnikova S, Chambers TM, Lvov DK, Webster RG: Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus. Virology 1990; 179:759-767.
19. Röhm C, Zhou N, Süss J, Mackenzie J, Webster RG: Characterization of a novel influenza hemagglutinin, H15: criteria for determination of influenza A subtypes. Virology 1996; 217:508-516.
20. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y: Evolution and ecology of influenza A viruses. Microbiol Rev 1992; 56: 152-179.
21. Butler D: Thai dogs carry bird-flu virus, but will they spread it? Nature 2006; 439:773.
22. Duke K: Germany says people in areas with bird flu should keep cats indoors. BMJ 2006; 332:568.
23. Keawcharoen J, Oraveerakul K, Kuiken T, Fouchier RA, Amonsin A, Payungporn S, Noppornpanth S, Wattanodorn S, Theam-booniers A, Tantilertcharoen R, Pattanarangsan R, Arya N, Ratanakorn P, Osterhaus DM, Poovorawan Y: Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004; 10:2189-2191.
24. Mase M, Tsukamoto K, Imada T, Imai K, Tanimura N Nakamura K, Yamamoto Y, Hitomi T, Kira T, Nakai T, Kiso M, Horimoto T, Kawaoka Y, Yamaguchi S: Characterization of H5N1 influenza a viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology 2005; 332: 167-176. (Pubitemid 40127238)
25. Webster RG, Hulse-Post DJ, Sturm-Ramirez KM, Guan Y Peiris M, Smith G, Chen H: Changing epidemiology and ecology of highly pathogenic avian H5N1 influenza viruses. Avian Dis 2007; 51: 269-272.
26. Choi YK, Nguyen TD, Ozaki H, Webby RJ, Puthavathana P, Buranathal C, Chaisingh A, Auewarakul P, Hanh NT, Ma SK, Hui PY, Guan Y Peiris JS, Webster RG: Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol 2005; 79: 10821-10825.
27. Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P: The guinea pig as a transmission model for human influenza viruses. Proc Natl Acad Sci USA 2006; 103: 9988-9992.
28. Reuman PD, Keely S, Schiff GM: Assessment of signs of influenza illness in the ferret model. J Virol Methods 1989; 24:27-34.
29. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD: Pathogenesis of influenza A (H5N1) virus infection in a primate model. J Virol 2001; 75: 6687-6691.
30. Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, Sambhara S, Tumpey TM, Katz JM: Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007; 81: 2736-2744.
31. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T: H5N1 virus attachment to lower respiratory tract. Science 2006; 312: 399.
32. Couceiro JN, Paulson JC, Baum LG: Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium: the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 1993; 29:155-165.
33. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD: Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 2004; 101:4620-4624.
34. Suzuki Y, Ito T, Suzuki T, Holland RE Jr, Chambers TM, Kiso M, Ishida H, Kawaoka Y: Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 2000; 74:11825-11831.
35. Ito T, Suzuki Y, Suzuki T, Takada A, Hori-moto T, Wells K Kida H, Otsuki K, Kiso M, Ishida H, Kawaoka Y: Recognition ofJV-gly-colylneuraminic acid linked to galactose by the α2,3 linkage is associated with intestinal replication of influenza A virus in ducks. J Virol 2000; 74: 9300-9305.
36. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y: Avian flu: influenza virus re-ceptors in the human airway. Nature 2006; 440: 435-436.
37. Olofsson S, Kumlin U, Dimock K, Arnberg N: Avian influenza and sialic acid receptors: more than meets the eye? Lancet Infect Dis 2005; 5: 184-188.
38. Yang ZY, Wei CJ, Kong WP, Wu L, Xu L, Smith DF, Nabel GJ: Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity. Science 2007; 317: 825-828.
39. Yamada S, Suzuki Y, Suzuki T, Le MQ, Ni-dom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y: Haemagglutinin mu-tations responsible for the binding of H5N1 influenza A viruses to human-type recep-tors. Nature 2006; 444: 378-382.
40. Stevens J, Blixt O, Tumpey TM, Taubenber-ger JK, Paulson JC, Wilson IA: Structure and receptor specificity of the hemaggluti-nin from an H5N1 influenza virus. Science 2006; 312:404-410.
41. Stevens J, Blixt O, Chen LM, Donis RO, Paul-son JC, Wilson IA: Recent avian H5N1 vi-ruses exhibit increased propensity for ac-quiring human receptor specificity. J Mol Biol 2008; 381: 1382-1394.
42. Resa-Infante P, Jorba N, Zamarreno N, Fernandez Y, Juarez S, Ortin J: The host-depen-dent interaction of alpha-importins with in-fluenza PB2 polymerase subunit is required for virus RNA replication. PloS One 2008; 3:e3904.
43. Manzoor R, Sakoda Y, Nomura N, Tsuda Y Ozaki H, Okamatsu M, Kida H: PB2 pro-tein of a highly pathogenic avian influenza virus strain A/chicken/Yamaguchi/7/2004 (H5N1) determines its replication potential in pigs. J Virol 2009; 83:1572-1578.
44. Chan PK: Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002; 34(suppl 2):S58-S64.
45. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen KY, Guan Y: Re-emergence of fatal human influenza A subtype H5N1 dis-ease. Lancet 2004; 363:617-619.
46. Wee SH, Park CK, Nam HM, Kim CH, Yoon H, Kim SJ, Lee ES, Lee BY, Kim JH, Lee JH, Kim CS: Outbreaks of highly pathogenic avi-an influenza (H5N1) in the Republic of Ko-rea in 2003/04. Vet Rec 2006; 158: 341-344.
47. Chotpitayasunondh T, Ungchusak K, Han-shaoworakul W, Chunsuthiwat S, Sawan-panyalert P, Kijphati R, Lochindarat S, Srisan P, Suwan P, Osotthanakorn Y Anantasetagoon T, Kanjanawasri S, Tanu-pattarachai S, Weerakul J, Chaiwirattana R Maneerattanaporn M, Poolsavathitikool R Chokephaibulkit K, Apisarnthanarak A, Dowell SF: Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11: 201-209.
48. Tiensin T, Chaitaweesub P, Songserm T, Chaisingh A, Hoonsuwan W, Buranathai C, Parakamawongsa T, Premashthira S, Amon-sin A, Gilbert M, Nielen M, Stegeman A: Highly pathogenic avian influenza H5N1, Thailand, 2004. Emerg Infect Dis 2005; 11: 1664-1672.
49. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO 28 January 2004. Geneva World Health Organization, 2004. http://www. who.int/csr/disease/avian-influenza/coun-try/cases-table-2004-10-25/ en/index.html (accessed February 11 2010).
50. Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC, Pham TS, Vo CD, Le TQ, Ngo TT, Dao BK, Le PP, Nguyen TT, Hoang TL, Cao VT, Le TG, Nguyen DT, Le HN, Nguyen KT, Le HS, Le VT, Christiane D, Tran TT, de Jong M, Schultsz C, Cheng P, Lim W, Horby P, Farrar J: Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350: 1179-1188.
51. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY: Avian influenza A (H5N1) infec-tion in humans. N Engl J Med 2005; 353: 1374-1385. (Pubitemid 41362705)
52. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N Soeroso S, Uyeki TM: Update on avian influ-enza A (H5N1) virus infection in humans. N Engl J Med 2008; 358: 261-273.
53. Outbreak news: Avian influenza, Egypt: update. Wkly Epidemiol Rec 2006; 81: 189.
54. Outbreak news: Avian influenza, Iraq: update. Wkly Epidemiol Rec 2006; 81: 50-51.
55. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO 2 June 2009. Geneva World Health Organization, 2009. http://www.who.int/csr/disease/avian-influenza/country/cases-table-2009-2006- 2002/en/index.html (accessed February 11 2010).
56. Oner AF, Bay A, Arslan S, Akdeniz H, Sahin HA, Cesur Y, Epcacan S, Yilmaz N, Deger I, Kizilyildiz B, Karsen H, Ceyhan M: Avian influenza A (H5N1) infection in Eastern Turkey in 2006. N Engl J Med 2006; 355: 2179-2185.
57. Katz JM, Lim W, Bridges CB, Rowe T, Hu-Primmer J, Lu X, Abernathy RA, Clarke M, Conn L, Kwong H, Lee M, Au G, Ho Y Y, Mak KH, Cox NJ, Fukuda K: Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social con-tacts. J Infect Dis 1999; 180: 1763-1770.
58. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S: Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352: 333-340.
59. Buxton Bridges C, Katz JM, Seto WH, Chan PK, Tsang D Ho W, Mak KH, Lim W, Tam JS, Clarke M, Williams SG, Mounts AW, Bre-see JS, Conn LA, Rowe T, Hu-Primmer J, Abernathy RA, Lu X, Cox N J, Fukuda K: Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000; 181:344-348.
60. Yang Y, Halloran ME, Sugimoto JD, Longini IM Jr: Detecting human-to-human trans-mission of avian influenza A (H5N1). Emerg Infect Dis 2007; 13: 1348-1353.
61. Sedyaningsih ER, Isfandari S, Setiawaty V, Rifati L, Harun S, Purba W, Imari S, Giri-putra S, Blair PJ, Putnam SD, Uyeki TM, Soendoro T: Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. J Infect Dis 2007; 196: 522-527.
62. Chen H: H5N1 avian influenza in China. Science 2009; 52:419-427.
63. Dudley JP: Age-specific infection and death rates for human A (H5N1) avian influenza in Egypt. Euro Surveill 2009; 14:pii 19198.
64. Takano R, Nidom CA, Kiso M, Muramoto Y, Yamada S, Sakai-Tagawa Y, Macken C, Kawaoka Y: Phylogenetic characterization of H5N1 avian influenza viruses isolated in In-donesia from 2003-2007. Virology 2009; 390: 13-21.
65. Uyeki TM: Global epidemiology of human infections with highly pathogenic avian in-fluenza A (H5N1) viruses. Respirology 2008; 13(suppl 1):S2-S9.
66. World Health Organization: Human avian influenza in Azerbaijan, February-March 2006. Wkly Epidemiol Rec 2006; 81:183-188.
67. Xu C, Dong L, Xin L, Lan Y, Chen Y, Yang L, Shu Y: Human avian influenza A (H5N1) vi-rus infection in China. Science 2009; 52:407-411.
68. Uyeki TM: Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009; 49: 279-290.
69. Hui DS: Review of clinical symptoms and spectrum in humans with influenza A/ H5N1 infection. Respirology 2008; 13(suppl 1):S10-S13.
70. Chutinimitkul S, Bhattarakosol P, Srisu-ratanon S, Eiamudomkan A, Kongsomboon K Damrongwatanapokin S, Chaisingh A, Suwannakarn K, Chieochansin T, Theam-boonlers A, Poovorawan Y: H5N1 influenza A virus and infected human plasma. Emerg Infect Dis 2006; 12:1041-1043.
71. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N: Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998; 279: 393-396.
72. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R, Cheng AF: Clinical features and rapid viral diagnosis of human disease asso-ciated with avian influenza A H5N1 virus. Lancet 1998; 351: 467-471.
73. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha DQ, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J: Fatal outcome of human influ-enza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203-1207.
74. de Jong MD, Hien TT: Avian influenza A (H5N1). J Clin Virol 2006; 35: 2-13.
75. Gruber PC, Gomersall CD, Joynt GM: Avian influenza (H5N1): implications for intensive care. Intensive Care Med 2006; 32:823-829.
76. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, Tran TH, Do QH, Farrar J: Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352: 686-691.
77. Uiprasertkul M, Puthavathana P, Sangsiri-wut K, Pooruk P, Srisook K, Peiris M, Nich-olls JM, Chokephaibulkit K, Vanprapar N Auewarakul P: Influenza A H5N1 replica-tion sites in humans. Emerg Infect Dis 2005; 11:1036-1041.
78. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, Long HT, Hien NT, Mai LQ, Taylor WR Wertheim H, Farrar J, Khang DD, Horby P: Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009; 48:1639-1646.
79. To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, Tang NL, Tsang DN, Sung RY, Buckley TA, Tam JS, Cheng AF: Pathol-ogy of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol 2001; 63:242-246.
80. Sandrock C, Kelly T: Clinical review: update of avian influenza A infections in humans. Crit Care 2007; 11:209.
81. Apisarnthanarak A, Kitphati R, Thongphu-beth K Patoomanunt P, Anthanont P, Au-wanit W, Thawatsupha P, Chittaganpitch M, Saeng-Aroon S, Waicharoen S, Apisarn-thanarak P, Storch GA, Mundy LM, Fraser VJ: Atypical avian influenza (H5N1). Emerg Infect Dis 2004; 10:1321-1324.
82. Clinical management of human infection with avian influenza A (H5N1) virus 2007: updated advice 15 August 2007. Geneva World Health Organization, 2007. http:// www.who.int/csr/disease/avian-influenza/guidelines/ ClinicalManagement07.pdf (accessed February 11 2010).
83. Chen H, Smith GJ, Li KS, Wang J, Fan XH, Rayner JM, Vijaykrishna D, Zhang JX, Zhang LJ, Guo CT, Cheung CL, Xu KM, Duan L, Huang K, Qin K, Leung YH, Wu WL, Lu HR, Chen Y, Xia NS, Naipospos TS, Yuen KY, Hassan SS, Bahri S, Nguyen TD, Webster RG, Peiris JS, Guan Y: Establish-ment of multiple sublineages of H5N1 influ-enza virus in Asia: implications for pandem-ic control. Proc Natl Acad Sci USA 2006; 103: 2845-2850.
84. Cheung CL, Rayner JM, Smith GJ, Wang P, Naipospos TS, Zhang J, Yuen KY, Webster RG, Peiris JS, Guan Y, Chen H: Distribution of amantadine-resistant H5N1 avian influ-enza variants in Asia. J Infect Dis 2006; 193: 1626-1629.
85. Regoes RR, Bonhoeffer S: Emergence of drug-resistant influenza virus: population-dynamical considerations. Science 2006; 312: 389-391.
86. Yen HL, Monto AS, Webster RG, Govorkova EA: Virulence may determine the necessary duration and dosage of oseltamivir treat-ment for highly pathogenic A/Vietnam/ 1203/04 influenza virus in mice. J Infect Dis 2005; 192: 665-672.
87. de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J: Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005; 353: 2667-2672.
88. Kiso M, Mitamura K, Sakai-Tagawa Y, Shi-raishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N Kawaoka Y: Resistant influ-enza A viruses in children treated with osel-tamivir: descriptive study. Lancet 2004; 364: 759-765.
89. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Meijer A, van Steenbergen J, Fouchier R, Osterhaus A, Bos-man A: Transmission of H7N7 avian influ-enza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004; 363: 587-593.
90. Kandun IN, Tresnaningsih E, Purba WH, Lee V, Samaan G, Harun S, Soni E, Septiawa-ti C, Setiawati T, Sariwati E, Wandra T: Fac-tors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 2008; 372: 744-749.
91. Le MT, Wertheim HF, Nguyen HD, Taylor W, Hoang PV, Vuong CD, Nguyen HL, Nguyen HH, Nguyen TQ, Nguyen TV, Van TD, Ngoc BT, Bui TN, Nguyen BG, Nguyen LT, Luong ST, Phan PH, Pham HV, Nguyen T, Fox A, Nguyen CV, Do HQ, Crusat M, Far-rar J, Nguyen HT, de Jong MD, Horby P: In-fluenza A H5N1 clade 2.3.4 virus with a dif-ferent antiviral susceptibility profile replaced clade 1 virus in humans in northern Viet-nam. PloS One 2008; 3:e3339.
92. Le QM, Kiso M, Someya K, Sakai YT, Ngu-yen TH, Nguyen KH, Pham ND, Nguyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y Kawaoka Y: Avian flu: isolation of drug-re-sistant H5N1 virus. Nature 2005; 437:1108.
93. de Clercq E: Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 2006; 5:1015-1025.
94. Hammer S, Inouye R: Antiviral agents; in Richman DD, Whiteley RJ, Hayden FG (eds): Clinical Virology, ed 2. Washington, ASM, 2002, pp 171-242.
95. Yu H, Gao Z, Feng Z, Shu Y, Xiang N, Zhou L, Huai Y Feng L, Peng Z, Li Z, Xu C, Li J, Hu C, Li Q, Xu X Liu X Liu Z, Xu L, Chen Y, Luo H, Wei L, Zhang X Xin J, Guo J, Wang Q, Yuan Z, Zhou L, Zhang K, Zhang W, Yang J, Zhong X, Xia S, Li L, Cheng J, Ma E, He P, Lee SS, Wang Y Uyeki TM, Yang W: Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PloS One 2008; 3:e2985.
96. Wang H, Feng Z, Shu Y, Yu H, Zhou L, Zu R Huai Y Dong J, Bao C, Wen L, Wang H, Yang P, Zhao W, Dong L, Zhou M, Liao Q, Yang H, Wang M, Lu X Shi Z, Wang W, Gu L, Zhu F, Li Q, Yin W, Yang W, Li D, Uyeki TM, Wang Y: Probable limited person-to-person trans-mission of highly pathogenic avian influen-za A (H5N1) virus in China. Lancet 2008; 371:1427-1434.
97. Ilyushina NA, Hay A, Yilmaz N, Boon AC, Webster RG, Govorkova EA: Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother 2008; 52:3889-3897.
98. Zhou B, Zhong N, Guan Y: Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007; 357: 1450-1451.
99. Sambhara S, Bridges CB, Poland GA: H5N1 vaccine hits the target, but not the bull's eye. Lancet Infect Dis 2007; 7:503-505.
100. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine virus-es developed for potential use in human vaccines, February 2009. Wkly Epidemiol Rec 2009; 84:72-76.
101. Rudenko L, Desheva J, Korovkin S, Mironov A, Rekstin A, Grigorieva E, Donina S, Gambaryan A, Katlinsky A: Safety and im-munogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). Influenza Other Respi Viruses 2008; 2: 203-209.
102. Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ: Im-mune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis 2008; 198: 635-641.
103. Nolan TM, Richmond PC, Skeljo MV, Pearce G, Hartel G, Formica NT, Hoschler K Bennet J, Ryan D, Papanaoum K, Basser RL, Zambon MC: Phase I and II ran-domised trials of the safety and immunoge-nicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. Vaccine 2008; 26: 4160-4167
104. Interim guidance on the planning for the use of surgical masks and respirators in health care settings during an influenza pandemic. US Department of Health and Human Services, 2009. http://www.pan-demicflu.gov/plan/healthcare/ maskguid-ancehc.html (accessed February 11, 2010).